[NBY] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
21-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 43.71%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 9,934 6,599 12,508 18,230 11,897 4,381 1,054 45.28%
PBT -11,034 -9,652 -6,541 -7,400 -13,149 -18,971 -15,192 -5.18%
Tax 5 6 4 3 2 12 2 16.48%
NP -11,039 -10,487 -6,545 -7,403 -13,151 -18,973 -15,194 -5.18%
Tax Rate - - - - - - - -
Total Cost 20,973 17,086 19,053 25,633 25,048 23,354 16,248 4.34%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -111.12 -158.92 -52.33 -40.61 -110.54 -433.07 -1,441.56 -34.73%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -385.53 -593.63 -473.83 -591.81 0.00 0.00 0.00 -
EPS Diluted -385.53 -593.63 -564.17 -591.81 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.